참고문헌
- State Administration of Traditional chiense medicine of the People's Republic of China. Zhonghuabencao. Vol. 9. Shanghai : Shanghai Scientific and Technical Publishers. 1999 : 354-6.
- Wu Y. Rihuazibencao. Hefei : AnhuiKexuejishu publisher. 2005 : 148-9.
- Choi GY, Yoon TS, Choo BK, Lee AY, Chae SU, Ju YS, Kim HK. Study on the Medicinal Parts and Expected Efficacys of the Hibiscus syriacus by Literature Review on the Classics of Oriental Medicine. Kor J Orient Med. 2007 ; 13(2) : 27-36.
- Tian DH. Shiyongzhongyaocidian. Beijing : Renminweisheng publisher. 2002 : 291-2.
- Yun BS, Lee IK, Ryoo IJ, Yoo ID. Coumarins with monoamine oxidase inhibitory activity and antioxidative coumarins-lignans from Hibiscus syriacus. J Nat Prod. 2001 ; 64(9) : 1238-40. https://doi.org/10.1021/np0100946
- Kwon SW, Hong SS, Kim JI, Ahn IH. Antioxidant properties of heat-treated Hibiscus syriacus. Izv Akad Nauk Ser Biol. 2003 ; (1) : 20-1.
- Choi KW, Lee SR, Jung IC. Effects of ChongMyung-Tang and ChongMyung-Tang added Hibiscus syriacus Hot water extract & Ultra-fine Powder on Microglia and Memory Deficit Model. Kor J Orient Physiol Pathol. 2006 ; 20(5) : 1200-10.
-
Park JU, Jung IC, Lee SR. The Effects of ChongMyungTang(CMT) and ChongMyungTang added Hibiscus syriacus(MCMT) Extract on the Alzheimer's Disease Model Induced by CT-105 and
$\beta$ A. J Orient Neuropsychiatry. 2006 ; 17(1) : 37-57. - Park GG. Gugangsaenghwahak. Seoul : Gunja publisher. 1999 : 318-25.
- Weissman BA, Gross SS. Measurement of NO and NO synthase. Curr Protoc Neurosci. 2001 ; 7(7) : 13.
- Politch JA, Tucker L, Bowman FP, Anderson DJ. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum Reprod. 2007 ; 22(11) : 2928-35. https://doi.org/10.1093/humrep/dem281
- Gangsosinuihakwon. Jungyakdasajeon Vol. 4. Seoul : Jeongdam publisher. 1998 : 1766-7.
- Lee CB. Wonsaekdaehansikmuldogam. Seoul : Hyangmunsa. 2006 : 736.
- Lu GP, Liu LR. Changyongzhongyaocaichuantongjianbie. Beijing : Renminweisheng publisher. 2005 : 465-6.
- Yoo KO, Lim HT, Kim JH. Studies on the flavonoids of the Hibiscus syriacus L. complex. Kor J Plant Res. 1996 ; 9(3) : 224-9.
- Willoughby DA. Human arthritis applied to animal models. Toward a better therapy. Ann Rheum Dis. 1975 ; 34(6) : 471-8. https://doi.org/10.1136/ard.34.6.471
- Lazarov S, Balutsov M, Ianev E. The role of bacterial endotoxins, receptors and cytokines in the pathogenesis of septic (endotoxin) shock. Vutr Boles. 2000 ; 32(4) : 33-40.
-
Lee ES, Ju HK, Moon TC, Lee E, Jahng Y, Lee SH, Son JK, Baek SH, Chang HW. Inhibition of nitric oxide and tumor necrosis factor-
$\alpha$ (TNF-$\alpha$ ) production by propenone compound through blockade of nuclear factor (NF)-$\kappa{B}$ activation in cultured murine macrophages. Biol Pharm Bull. 2004 ; 27(5) : 617-20. https://doi.org/10.1248/bpb.27.617 - Lee TH, Kwak HB, Kim HH, Lee ZH, Chung DK, Baek NI, Kim J. Methanol extracts of Stewartia koreana inhibit cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) gene expression by blocking NF-kappa B transactivation in LPS-activated Raw 264.7 cells. Mol Cells. 2007 ; 23(3) : 398-404.
-
Nishida T, Yabe Y, Fu HY, Hayashi Y, Asahi K, Eguchi H, Tsuji S, Tsujii M, Hayashi N, Kawano S. Geranylgeranylacetone induces cyclooxygenase-2 expression in cultured rat gastric epithelial cells through NF-
$\kappa{B}$ . Dig Dis Sci. 2007 ; 52(8) : 1890-6. https://doi.org/10.1007/s10620-006-9661-8 - Heo Y, Kim HA. Review on Experimental Methods for Investigation of Atopic Dermatitis. Kor J public health. 2007 ; 44(1) : 81-6.
- Bagley CJ, Lopez AF, Vadas MA. Updates on cells and cytokines; New frontiers for IL-5. J Allergy Clin Immunol. 1997 ; 99(6) : 725-8. https://doi.org/10.1016/S0091-6749(97)80002-4
- Pajkrt D, Camoglio L, Tiel-van Buul MC, de Bruin K, Cutler DL, Affrime MB, Rikken G, van der Poll T, ten Cate JW, van Deventer SJ. Attenuation of proinflammatory response by recombinant IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J Immunol. 1997 ; 158(8) : 3971-7.
-
Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D. Utilization of the
$\beta$ and$\gamma$ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 1994 ; 13(12) : 2822-30. -
Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-
$\gamma$ by natural killer cells in vitro. J Clin Invest. 1995 ; 96(6) : 2578-82. https://doi.org/10.1172/JCI118321 -
Kim YH, Yoon HJ, Moon ME, Lee JH, Park HS, Kim JS. Production of NO, TNF-
$\alpha$ and IL-6 by Squalene, Alkoxy Glycerol, Batyl and Chimyl Solutions in RAW 264.7 Macrophage Cells. J Korean Soc Food Sci Nutr. 2005 ; 34(10) : 1503-8. https://doi.org/10.3746/jkfn.2005.34.10.1503 - Orme IM, Roberts AD, Griffin JP, Abrams JS. Cytokine secretion by CD4+ T lympocytes aquired in response to mycobacterium tuberculosis infection. J Immunol. 1993 ; 151(1) : 518-25.
- Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989 ; 161(2) : 851-8. https://doi.org/10.1016/0006-291X(89)92678-8
- Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpemeability, and angiogenesis. Am J Pathol. 1995 ; 146(5) : 1029-39.
- Costello RT. Therapeutic use of granulocyte-macrophage colony-stimulating factor (GM-CSF). A review of recent experience. Acta Oncol. 1993 ; 32(4) : 403-8. https://doi.org/10.3109/02841869309093617
- Lopez AF, Eglinton JM, Lyons AB, Tapley PM, To LB, Park LS, Clark SC, Vadas MA. Human interleukin-3 inhibits the binding of granulocyte-macrophage colony-stimulating factor and interleukin-5 to basophils and strongly enhances their functional activity. J Cell Physiol. 1990 ; 145(1) : 69-77. https://doi.org/10.1002/jcp.1041450111
- Bukowski RM, Budd GT, Gibbons JA, Bauer RJ, Childs A, Antal J, Finke J, Tuason L, Lorenzi V, McLain D. Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects. J Clin Oncol. 1994 ; 12(1) : 97-106. https://doi.org/10.1200/JCO.1994.12.1.97
- Sakurai T, Suzu S, Yamada M, Yanai N, Kawashima T, Hatake K, Takaku F, Motoyoshi K. Induction of Tumor Necrosis Factor in Mice by Recombinant Human macrophage colony-stimulating Factor. Jpn J Cancer Res. 1994 ; 85(1) : 80-5. https://doi.org/10.1111/j.1349-7006.1994.tb02889.x